Changes in body weight during pharmacological treatment of depression.
暂无分享,去创建一个
M. Rietschel | A. Farmer | P. McGuffin | W. Maier | J. Mendlewicz | O. Mors | J. Hauser | N. Henigsberg | D. Souery | K. Aitchison | R. Uher | A. Placentino | J. Strohmaier | A. Szczepankiewicz | A. Zobel | Petra Kalember | D. Kozel | J. Gray | R. Keers | E. Larsen | M. Dernovšek
[1] J. K. Wing,et al. Diagnosis and clinical measurement in psychiatry , 2013 .
[2] M. Rietschel,et al. Variation in GNB3 predicts response and adverse reactions to antidepressants , 2011, Journal of psychopharmacology.
[3] Theo Stijnen,et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. , 2010, Archives of general psychiatry.
[4] C. Wilcox,et al. Body mass index and response to antidepressants in depressed research subjects. , 2009, The Journal of clinical psychiatry.
[5] M. Rietschel,et al. Body weight as a predictor of antidepressant efficacy in the GENDEP project. , 2009, Journal of affective disorders.
[6] Marcella Rietschel,et al. Adverse reactions to antidepressants. , 2009, The British journal of psychiatry : the journal of mental science.
[7] T. Werge,et al. Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1 , 2009, International clinical psychopharmacology.
[8] M. Fava,et al. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report , 2009, Psychological Medicine.
[9] Scott B. Patten,et al. Major Depression, Antidepressant Medication and the Risk of Obesity , 2009, Psychotherapy and Psychosomatics.
[10] M. Rietschel,et al. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression , 2009, British Journal of Psychiatry.
[11] P. McGorry,et al. Non-pharmacological management of antipsychotic-induced weight gain: Systematic review and meta-analysis of randomised controlled trials , 2008, British Journal of Psychiatry.
[12] P. Lane. Handling drop‐out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches , 2008, Pharmaceutical statistics.
[13] S. Warden,et al. Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies. , 2008, Journal of musculoskeletal & neuronal interactions.
[14] M. Rietschel,et al. Measuring depression: comparison and integration of three scales in the GENDEP study , 2007, Psychological Medicine.
[15] J. Goethe,et al. Selective Serotonin Reuptake Inhibitor Discontinuation: Side Effects and Other Factors That Influence Medication Adherence , 2007, Journal of clinical psychopharmacology.
[16] F. Holsboer,et al. Overweight and Obesity Affect Treatment Response in Major Depression , 2007, Biological Psychiatry.
[17] W. Brown,et al. BMI, sex, and antidepressant response. , 2007, Journal of affective disorders.
[18] K. Demyttenaere,et al. What happens with adverse events during 6 months of treatment with selective serotonin reuptake inhibitors? , 2005, The Journal of clinical psychiatry.
[19] M. Fava,et al. Obesity among outpatients with major depressive disorder. , 2005, The international journal of neuropsychopharmacology.
[20] J. Krystal,et al. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. , 2004, Archives of general psychiatry.
[21] M. Fava,et al. Nortriptyline for treatment-resistant depression. , 2003, The Journal of clinical psychiatry.
[22] A. Astrup,et al. Obesity : Preventing and managing the global epidemic , 2000 .
[23] M. Fava,et al. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment. , 2000, The Journal of clinical psychiatry.
[24] M. Fava,et al. Weight gain and antidepressants. , 2000, The Journal of clinical psychiatry.
[25] J. Amsterdam,et al. Changes in weight during a 1-year trial of fluoxetine. , 1999, The American journal of psychiatry.
[26] F. Benazzi. Weight Gain in Depression Remitted with Antidepressants: Pharmacological or Recovery Effect? , 1998, Psychotherapy and Psychosomatics.
[27] B. Pollock,et al. Nortriptyline and weight change in depressed patients over 60. , 1992, Journal of clinical psychopharmacology.
[28] D. Kupfer,et al. Antidepressant-induced weight gain: A comparison study of four medications , 1988, Psychiatry Research.
[29] U. Ahlfors,et al. The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients , 1987, Acta psychiatrica Scandinavica. Supplementum.
[30] Warren C. Stern,et al. Weight gain. A side-effect of tricyclic antidepressants. , 1984, Journal of affective disorders.
[31] M. Åsberg,et al. A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.
[32] E. Paykel,et al. Amitriptyline, Weight Gain and Carbohydrate Craving: A Side Effect , 1973, British Journal of Psychiatry.
[33] S. Beaulieu,et al. Pharmacological Management of Atypical Antipsychotic-Induced Weight Gain , 2008, CNS drugs.
[34] Paolo Cassano,et al. Tolerability issues during long-term treatment with antidepressants. , 2004, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.